Eshoo

Washington, D.C., Oct. 18, 2022 (GLOBE NEWSWIRE) -- During UsAgainstAlzheimer’s 2022 National Summit, members of Congress, scientists, and other leaders spoke out against the Centers for Medicare and Medicaid Services (CMS) decision to…

Washington, DC, Oct. 12, 2022 (GLOBE NEWSWIRE) -- With the federal government’s decision to deny Medicare coverage of an entire class of Alzheimer’s treatments, as well as the promising clinical trial data regarding lecanemab released…